{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:12:14Z","timestamp":1747458734386},"publisher-location":"Cham","reference-count":235,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319896885"},{"type":"electronic","value":"9783319896892"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-89689-2_8","type":"book-chapter","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T12:01:22Z","timestamp":1529323282000},"page":"213-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Deregulation of RNA Metabolism in Microsatellite Expansion Diseases"],"prefix":"10.1007","author":[{"given":"Chaitali","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feikai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auinash","family":"Kalsotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"issue":"3","key":"8_CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbagrm.2017.01.004","volume":"1860","author":"W Arif","year":"2017","unstructured":"Arif W, Datar G, Kalsotra A. Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism. Biochim Biophys Acta. 2017;1860(3):349\u201362.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"8_CR2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm.2016.163","volume":"18","author":"CJ Lewis","year":"2017","unstructured":"Lewis CJ, Pan T, Kalsotra A. RNA modifications and structures cooperate to guide RNA-protein interactions. Nat Rev Mol Cell Biol. 2017;18(3):202\u201310.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"8_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrg.2015.3","volume":"17","author":"MM Scotti","year":"2016","unstructured":"Scotti MM, Swanson MS. RNA mis-splicing in disease. Nat Rev Genet. 2016;17(1):19\u201332.","journal-title":"Nat Rev Genet"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2016.02.050","volume":"1647","author":"AE Brinegar","year":"2016","unstructured":"Brinegar AE, Cooper TA. Roles for RNA-binding proteins in development and disease. Brain Res. 2016;1647:1\u20138.","journal-title":"Brain Res"},{"issue":"7147","key":"8_CR5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature05977","volume":"447","author":"SM Mirkin","year":"2007","unstructured":"Mirkin SM. Expandable DNA repeats and human disease. Nature. 2007;447(7147):932\u201340.","journal-title":"Nature"},{"issue":"4","key":"8_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrg2748","volume":"11","author":"AR Spada La","year":"2010","unstructured":"La Spada AR, Taylor JP. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet. 2010;11(4):247\u201358.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"8_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2011.10.006","volume":"97","author":"AJ Renoux","year":"2012","unstructured":"Renoux AJ, Todd PK. Neurodegeneration the RNA way. Prog Neurobiol. 2012;97(2):173\u201389.","journal-title":"Prog Neurobiol"},{"issue":"12","key":"8_CR8","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1074\/jbc.R800025200","volume":"284","author":"JR O\u2019Rourke","year":"2009","unstructured":"O\u2019Rourke JR, Swanson MS. Mechanisms of RNA-mediated disease. J Biol Chem. 2009;284(12):7419\u201323.","journal-title":"J Biol Chem"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gde.2017.01.005","volume":"44","author":"N Zhang","year":"2017","unstructured":"Zhang N, Ashizawa T. RNA toxicity and foci formation in microsatellite expansion diseases. Curr Opin Genet Dev. 2017;44:17\u201329.","journal-title":"Curr Opin Genet Dev"},{"issue":"7657","key":"8_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22386","volume":"546","author":"A Jain","year":"2017","unstructured":"Jain A, Vale RD. RNA phase transitions in repeat expansion disorders. Nature. 2017;546(7657):243\u20137.","journal-title":"Nature"},{"issue":"4998","key":"8_CR11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.2006411","volume":"251","author":"D Heitz","year":"1991","unstructured":"Heitz D, Rousseau F, Devys D, Saccone S, Abderrahim H, Le Paslier D, Cohen D, Vincent A, Toniolo D, Della Valle G, et al. Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science. 1991;251(4998):1236\u20139.","journal-title":"Science"},{"issue":"5013","key":"8_CR12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.1675488","volume":"252","author":"EJ Kremer","year":"1991","unstructured":"Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science. 1991;252(5013):1711\u20134.","journal-title":"Science"},{"issue":"5009","key":"8_CR13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.252.5009.1097","volume":"252","author":"I Oberle","year":"1991","unstructured":"Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991;252(5009):1097\u2013102.","journal-title":"Science"},{"issue":"5","key":"8_CR14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"AJ Verkerk","year":"1991","unstructured":"Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905\u201314.","journal-title":"Cell"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","volume":"35","author":"AL Bhakar","year":"2012","unstructured":"Bhakar AL, Dolen G, Bear MF. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci. 2012;35:417\u201343.","journal-title":"Annu Rev Neurosci"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","volume":"7","author":"MR Santoro","year":"2012","unstructured":"Santoro MR, Bray SM, Warren ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol. 2012;7:219\u201345.","journal-title":"Annu Rev Pathol"},{"issue":"5133","key":"8_CR17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7692601","volume":"262","author":"CT Ashley Jr","year":"1993","unstructured":"Ashley CT Jr, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. 1993;262(5133):563\u20136.","journal-title":"Science"},{"issue":"25","key":"8_CR18","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1074\/jbc.273.25.15521","volume":"273","author":"V Brown","year":"1998","unstructured":"Brown V, Small K, Lakkis L, Feng Y, Gunter C, Wilkinson KD, Warren ST. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem. 1998;273(25):15521\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(94)90232-1","volume":"77","author":"H Siomi","year":"1994","unstructured":"Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell. 1994;77(1):33\u20139.","journal-title":"Cell"},{"issue":"2","key":"8_CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90420-U","volume":"74","author":"H Siomi","year":"1993","unstructured":"Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell. 1993;74(2):291\u20138.","journal-title":"Cell"},{"issue":"6330","key":"8_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR Spada La","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77\u20139.","journal-title":"Nature"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575\u2013621.","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"8_CR23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90(3):537\u201348.","journal-title":"Cell"},{"issue":"5334","key":"8_CR24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277(5334):1990\u20133.","journal-title":"Science"},{"issue":"2","key":"8_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19(2):333\u201344.","journal-title":"Neuron"},{"issue":"6","key":"8_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tins.2010.03.004","volume":"33","author":"LB Li","year":"2010","unstructured":"Li LB, Bonini NM. Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci. 2010;33(6):292\u20138.","journal-title":"Trends Neurosci"},{"issue":"10","key":"8_CR27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrg1691","volume":"6","author":"JR Gatchel","year":"2005","unstructured":"Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet. 2005;6(10):743\u201355.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"8_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245\u201356.","journal-title":"Neuron"},{"issue":"2","key":"8_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257\u201368.","journal-title":"Neuron"},{"issue":"4","key":"8_CR30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW III, Rademakers R, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron. 2013;77(4):639\u201346.","journal-title":"Neuron"},{"issue":"6125","key":"8_CR31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS. Science. 2013;339(6125):1335\u20138.","journal-title":"Science"},{"issue":"19","key":"8_CR32","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.1219643110","volume":"110","author":"Z Xu","year":"2013","unstructured":"Xu Z, Poidevin M, Li X, Li Y, Shu L, Nelson DL, Li H, Hales CM, Gearing M, Wingo TS, et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci U S A. 2013;110(19):7778\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"8_CR33","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","volume":"110","author":"T Zu","year":"2013","unstructured":"Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A. 2013;110(51):E4968\u201377.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"8_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","volume":"17","author":"NA Faustino","year":"2003","unstructured":"Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003;17(4):419\u201337.","journal-title":"Genes Dev"},{"issue":"4","key":"8_CR35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.nurt.2008.08.001","volume":"5","author":"TM Wheeler","year":"2008","unstructured":"Wheeler TM. Myotonic dystrophy: therapeutic strategies for the future. Neurotherapeutics. 2008;5(4):592\u2013600.","journal-title":"Neurotherapeutics"},{"key":"8_CR36","volume-title":"Myotonic dystrophy","author":"P Harper","year":"2001","unstructured":"Harper P. Myotonic dystrophy. London: W.B. Saunders; 2001."},{"issue":"4","key":"8_CR37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell. 1992;68(4):799\u2013808.","journal-title":"Cell"},{"issue":"5049","key":"8_CR38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","volume":"255","author":"M Mahadevan","year":"1992","unstructured":"Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O\u2019Hoy K, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene. Science. 1992;255(5049):1253\u20135.","journal-title":"Science"},{"issue":"5531","key":"8_CR39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293(5531):864\u20137.","journal-title":"Science"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","volume":"44","author":"K Yum","year":"2017","unstructured":"Yum K, Wang ET, Kalsotra A. Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. Curr Opin Genet Dev. 2017;44:30\u20137.","journal-title":"Curr Opin Genet Dev"},{"issue":"25","key":"8_CR41","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","volume":"358","author":"WJ Groh","year":"2008","unstructured":"Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008;358(25):2688\u201397.","journal-title":"N Engl J Med"},{"issue":"4","key":"8_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","volume":"79","author":"C Heatwole","year":"2012","unstructured":"Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012;79(4):348\u201357.","journal-title":"Neurology"},{"issue":"1","key":"8_CR43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(96)00163-0","volume":"33","author":"MF Phillips","year":"1997","unstructured":"Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res. 1997;33(1):13\u201322.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"8_CR44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/gte.2006.0511","volume":"11","author":"LB Salehi","year":"2007","unstructured":"Salehi LB, Bonifazi E, Stasio ED, Gennarelli M, Botta A, Vallo L, Iraci R, Massa R, Antonini G, Angelini C, et al. Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients. Genet Test. 2007;11(1):84\u201390.","journal-title":"Genet Test"},{"issue":"3","key":"8_CR45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0796-316","volume":"13","author":"G Jansen","year":"1996","unstructured":"Jansen G, Groenen PJ, Bachner D, Jap PH, Coerwinkel M, Oerlemans F, van den Broek W, Gohlsch B, Pette D, Plomp JJ, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet. 1996;13(3):316\u201324.","journal-title":"Nat Genet"},{"issue":"4","key":"8_CR46","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1172\/JCI5346","volume":"103","author":"CI Berul","year":"1999","unstructured":"Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, Housman D, Mendelsohn ME, Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest. 1999;103(4):R1\u20137.","journal-title":"J Clin Invest"},{"issue":"4","key":"8_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng0897-407","volume":"16","author":"CA Thornton","year":"1997","unstructured":"Thornton CA, Wymer JP, Simmons Z, McClain C, Moxley RT III. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet. 1997;16(4):407\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/75490","volume":"25","author":"TR Klesert","year":"2000","unstructured":"Klesert TR, Cho DH, Clark JI, Maylie J, Adelman J, Snider L, Yuen EC, Soriano P, Tapscott SJ. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat Genet. 2000;25(1):105\u20139.","journal-title":"Nat Genet"},{"issue":"5485","key":"8_CR49","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","volume":"289","author":"A Mankodi","year":"2000","unstructured":"Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science. 2000;289(5485):1769\u201373.","journal-title":"Science"},{"issue":"9","key":"8_CR50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molmed.2011.05.004","volume":"17","author":"M Gomes-Pereira","year":"2011","unstructured":"Gomes-Pereira M, Cooper TA, Gourdon G. Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol Med. 2011;17(9):506\u201317.","journal-title":"Trends Mol Med"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2012.02.030","volume":"1462","author":"GV Echeverria","year":"2012","unstructured":"Echeverria GV, Cooper TA. RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity. Brain Res. 2012;1462:100\u201311.","journal-title":"Brain Res"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gde.2014.03.002","volume":"26","author":"JD Cleary","year":"2014","unstructured":"Cleary JD, Ranum LP. Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders. Curr Opin Genet Dev. 2014;26:6\u201315.","journal-title":"Curr Opin Genet Dev"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2014.03.039","volume":"1584","author":"A Mohan","year":"2014","unstructured":"Mohan A, Goodwin M, Swanson MS. RNA-protein interactions in unstable microsatellite diseases. Brain Res. 2014;1584:3\u201314.","journal-title":"Brain Res"},{"issue":"3","key":"8_CR54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/dvdy.24240","volume":"244","author":"A Chau","year":"2015","unstructured":"Chau A, Kalsotra A. Developmental insights into the pathology of and therapeutic strategies for DM1: back to the basics. Dev Dyn. 2015;244(3):377\u201390.","journal-title":"Dev Dyn"},{"issue":"7280","key":"8_CR55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463(7280):457\u201363.","journal-title":"Nature"},{"issue":"10","key":"8_CR56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrg3052","volume":"12","author":"A Kalsotra","year":"2011","unstructured":"Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 2011;12(10):715\u201329.","journal-title":"Nat Rev Genet"},{"issue":"21","key":"8_CR57","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/dev.124.21.4321","volume":"124","author":"G Begemann","year":"1997","unstructured":"Begemann G, Paricio N, Artero R, Kiss I, Perez-Alonso M, Mlodzik M. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development. 1997;124(21):4321\u201331.","journal-title":"Development"},{"issue":"15","key":"8_CR58","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/sj.emboj.7600300","volume":"23","author":"TH Ho","year":"2004","unstructured":"Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA. Muscleblind proteins regulate alternative splicing. EMBO J. 2004;23(15):3103\u201312.","journal-title":"EMBO J"},{"issue":"4","key":"8_CR59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1567-133X(03)00064-4","volume":"3","author":"RN Kanadia","year":"2003","unstructured":"Kanadia RN, Urbinati CR, Crusselle VJ, Luo D, Lee YJ, Harrison JK, Oh SP, Swanson MS. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr Patterns. 2003;3(4):459\u201362.","journal-title":"Gene Expr Patterns"},{"issue":"17","key":"8_CR60","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1093\/nar\/gku767","volume":"42","author":"P Konieczny","year":"2014","unstructured":"Konieczny P, Stepniak-Konieczna E, Sobczak K. MBNL proteins and their target RNAs, interaction and splicing regulation. Nucleic Acids Res. 2014;42(17):10873\u201387.","journal-title":"Nucleic Acids Res"},{"issue":"51","key":"8_CR61","doi-asserted-by":"crossref","first-page":"20333","DOI":"10.1073\/pnas.0809045105","volume":"105","author":"A Kalsotra","year":"2008","unstructured":"Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, Cooper TA. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A. 2008;105(51):20333\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"8_CR62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cell.2012.06.041","volume":"150","author":"ET Wang","year":"2012","unstructured":"Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, Treacy DJ, Luo S, Schroth GP, Housman DE, Reddy S, et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell. 2012;150(4):710\u201324.","journal-title":"Cell"},{"issue":"2","key":"8_CR63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nsmb.1720","volume":"17","author":"H Du","year":"2010","unstructured":"Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol. 2010;17(2):187\u201393.","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"8_CR64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ncb1335","volume":"7","author":"Y Adereth","year":"2005","unstructured":"Adereth Y, Dammai V, Kose N, Li R, Hsu T. RNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1. Nat Cell Biol. 2005;7(12):1240\u20137.","journal-title":"Nat Cell Biol"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/srep00209","volume":"2","author":"A Masuda","year":"2012","unstructured":"Masuda A, Andersen HS, Doktor TK, Okamoto T, Ito M, Andresen BS, Ohno K. CUGBP1 and MBNL1 preferentially bind to 3\u2032 UTRs and facilitate mRNA decay. Sci Rep. 2012;2:209.","journal-title":"Sci Rep"},{"issue":"8","key":"8_CR66","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/hmg\/ddp058","volume":"18","author":"RJ Osborne","year":"2009","unstructured":"Osborne RJ, Lin X, Welle S, Sobczak K, O\u2019Rourke JR, Swanson MS, Thornton CA. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet. 2009;18(8):1471\u201381.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"8_CR67","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nsmb.2067","volume":"18","author":"F Rau","year":"2011","unstructured":"Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, Jost B, Dembele D, Gourdon G, Nicole A, Duboc D, et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol. 2011;18(7):840\u20135.","journal-title":"Nat Struct Mol Biol"},{"issue":"5652","key":"8_CR68","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for myotonic dystrophy. Science. 2003;302(5652):1978\u201380.","journal-title":"Science"},{"issue":"5","key":"8_CR69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/hmg\/ddh056","volume":"13","author":"Y Kino","year":"2004","unstructured":"Kino Y, Mori D, Oma Y, Takeshita Y, Sasagawa N, Ishiura S. Muscleblind protein, MBNL1\/EXP, binds specifically to CHHG repeats. Hum Mol Genet. 2004;13(5):495\u2013507.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"8_CR70","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1261\/rna.610607","volume":"13","author":"MB Warf","year":"2007","unstructured":"Warf MB, Berglund JA. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA. 2007;13(12):2238\u201351.","journal-title":"RNA"},{"issue":"16","key":"8_CR71","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1093\/nar\/gkm601","volume":"35","author":"Y Yuan","year":"2007","unstructured":"Yuan Y, Compton SA, Sobczak K, Stenberg MG, Thornton CA, Griffith JD, Swanson MS. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 2007;35(16):5474\u201386.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"8_CR72","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","volume":"11","author":"M Fardaei","year":"2002","unstructured":"Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet. 2002;11(7):805\u201314.","journal-title":"Hum Mol Genet"},{"issue":"24","key":"8_CR73","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet. 2004;13(24):3079\u201388.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"8_CR74","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","volume":"19","author":"JW Miller","year":"2000","unstructured":"Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 2000;19(17):4439\u201348.","journal-title":"EMBO J"},{"issue":"2","key":"8_CR75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","volume":"56","author":"R Batra","year":"2014","unstructured":"Batra R, Charizanis K, Manchanda M, Mohan A, Li M, Finn DJ, Goodwin M, Zhang C, Sobczak K, Thornton CA, et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol Cell. 2014;56(2):311\u201322.","journal-title":"Mol Cell"},{"issue":"3","key":"8_CR76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuron.2012.05.029","volume":"75","author":"K Charizanis","year":"2012","unstructured":"Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, Yuan Y, Shiue L, Cline M, Scotti MM, Xia G, et al. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron. 2012;75(3):437\u201350.","journal-title":"Neuron"},{"issue":"17","key":"8_CR77","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/hmg\/ddt209","volume":"22","author":"MG Poulos","year":"2013","unstructured":"Poulos MG, Batra R, Li M, Yuan Y, Zhang C, Darnell RB, Swanson MS. Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet. 2013;22(17):3547\u201358.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"8_CR78","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/emmm.201303275","volume":"5","author":"KY Lee","year":"2013","unstructured":"Lee KY, Li M, Manchanda M, Batra R, Charizanis K, Mohan A, Warren SA, Chamberlain CM, Finn D, Hong H, et al. Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol Med. 2013;5(12):1887\u2013900.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"8_CR79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033218","volume":"7","author":"K Suenaga","year":"2012","unstructured":"Suenaga K, Lee KY, Nakamori M, Tatsumi Y, Takahashi MP, Fujimura H, Jinnai K, Yoshikawa H, Du H, Ares M Jr, et al. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS One. 2012;7(3):e33218.","journal-title":"PLoS One"},{"issue":"7","key":"8_CR80","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2015.07.029","volume":"12","author":"M Goodwin","year":"2015","unstructured":"Goodwin M, Mohan A, Batra R, Lee KY, Charizanis K, Fernandez Gomez FJ, Eddarkaoui S, Sergeant N, Buee L, Kimura T, et al. MBNL sequestration by toxic RNAs and RNA misprocessing in the myotonic dystrophy brain. Cell Rep. 2015;12(7):1159\u201368.","journal-title":"Cell Rep"},{"issue":"19","key":"8_CR81","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/hmg\/10.19.2143","volume":"10","author":"N Sergeant","year":"2001","unstructured":"Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, Wattez A, Vermersch P, Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet. 2001;10(19):2143\u201355.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"8_CR82","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/MCB.21.4.1285-1296.2001","volume":"21","author":"AN Ladd","year":"2001","unstructured":"Ladd AN, Charlet N, Cooper TA. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 2001;21(4):1285\u201396.","journal-title":"Mol Cell Biol"},{"issue":"13","key":"8_CR83","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/nar\/29.13.2766","volume":"29","author":"M Fardaei","year":"2001","unstructured":"Fardaei M, Larkin K, Brook JD, Hamshere MG. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 2001;29(13):2766\u201371.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8_CR84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","volume":"28","author":"NM Kuyumcu-Martinez","year":"2007","unstructured":"Kuyumcu-Martinez NM, Wang GS, Cooper TA. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell. 2007;28(1):68\u201378.","journal-title":"Mol Cell"},{"issue":"7","key":"8_CR85","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1101\/gad.1894310","volume":"24","author":"A Kalsotra","year":"2010","unstructured":"Kalsotra A, Wang K, Li PF, Cooper TA. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 2010;24(7):653\u20138.","journal-title":"Genes Dev"},{"issue":"2","key":"8_CR86","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.celrep.2013.12.025","volume":"6","author":"A Kalsotra","year":"2014","unstructured":"Kalsotra A, Singh RK, Gurha P, Ward AJ, Creighton CJ, Cooper TA. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. Cell Rep. 2014;6(2):336\u201345.","journal-title":"Cell Rep"},{"issue":"13","key":"8_CR87","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","volume":"15","author":"X Lin","year":"2006","unstructured":"Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet. 2006;15(13):2087\u201397.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"8_CR88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nbd.2009.07.009","volume":"36","author":"R Pelletier","year":"2009","unstructured":"Pelletier R, Hamel F, Beaulieu D, Patry L, Haineault C, Tarnopolsky M, Schoser B, Puymirat J. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol Dis. 2009;36(1):181\u201390.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"8_CR89","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2353\/ajpath.2009.090047","volume":"175","author":"E Salisbury","year":"2009","unstructured":"Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, et al. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol. 2009;175(2):748\u201362.","journal-title":"Am J Pathol"},{"issue":"1","key":"8_CR90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","volume":"29","author":"RS Savkur","year":"2001","unstructured":"Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet. 2001;29(1):40\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"BN Charlet","year":"2002","unstructured":"Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell. 2002;10(1):45\u201353.","journal-title":"Mol Cell"},{"issue":"6","key":"8_CR92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1101\/gr.184390.114","volume":"25","author":"ET Wang","year":"2015","unstructured":"Wang ET, Ward AJ, Cherone JM, Giudice J, Wang TT, Treacy DJ, Lambert NJ, Freese P, Saxena T, Cooper TA, et al. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res. 2015;25(6):858\u201371.","journal-title":"Genome Res"},{"issue":"12","key":"8_CR93","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/nar\/gki698","volume":"33","author":"DH Kim","year":"2005","unstructured":"Kim DH, Langlois MA, Lee KB, Riggs AD, Puymirat J, Rossi JJ. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res. 2005;33(12):3866\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"8_CR94","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/sj.emboj.7601296","volume":"25","author":"S Paul","year":"2006","unstructured":"Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, Comai L, Reddy S. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J. 2006;25(18):4271\u201383.","journal-title":"EMBO J"},{"issue":"44","key":"8_CR95","doi-asserted-by":"crossref","first-page":"38427","DOI":"10.1074\/jbc.M111.255224","volume":"286","author":"S Paul","year":"2011","unstructured":"Paul S, Dansithong W, Jog SP, Holt I, Mittal S, Brook JD, Morris GE, Comai L, Reddy S. Expanded CUG repeats dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex. J Biol Chem. 2011;286(44):38427\u201338.","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/nar\/gkr729","volume":"40","author":"WJ Krzyzosiak","year":"2012","unstructured":"Krzyzosiak WJ, Sobczak K, Wojciechowska M, Fiszer A, Mykowska A, Kozlowski P. Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res. 2012;40(1):11\u201326.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"8_CR97","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/nar\/gkr1228","volume":"40","author":"FX Laurent","year":"2012","unstructured":"Laurent FX, Sureau A, Klein AF, Trouslard F, Gasnier E, Furling D, Marie J. New function for the RNA helicase p68\/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Res. 2012;40(7):3159\u201371.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"8_CR98","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2443.2007.01112.x","volume":"12","author":"I Holt","year":"2007","unstructured":"Holt I, Mittal S, Furling D, Butler-Browne GS, Brook JD, Morris GE. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells. 2007;12(9):1035\u201348.","journal-title":"Genes Cells"},{"issue":"6","key":"8_CR99","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.200706048","volume":"178","author":"KP Smith","year":"2007","unstructured":"Smith KP, Byron M, Johnson C, Xing Y, Lawrence JB. Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains. J Cell Biol. 2007;178(6):951\u201364.","journal-title":"J Cell Biol"},{"issue":"6","key":"8_CR100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.molcel.2016.01.020","volume":"61","author":"JM Taliaferro","year":"2016","unstructured":"Taliaferro JM, Vidaki M, Oliveira R, Olson S, Zhan L, Saxena T, Wang ET, Graveley BR, Gertler FB, Swanson MS, et al. Distal alternative last exons localize mRNAs to neural projections. Mol Cell. 2016;61(6):821\u201333.","journal-title":"Mol Cell"},{"issue":"45","key":"8_CR101","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1523\/JNEUROSCI.2352-16.2016","volume":"36","author":"ET Wang","year":"2016","unstructured":"Wang ET, Taliaferro JM, Lee JA, Sudhakaran IP, Rossoll W, Gross C, Moss KR, Bassell GJ. Dysregulation of mRNA localization and translation in genetic disease. J Neurosci. 2016;36(45):11418\u201326.","journal-title":"J Neurosci"},{"issue":"2","key":"8_CR102","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2007.11.024","volume":"29","author":"IA Vlasova","year":"2008","unstructured":"Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, Sternjohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, et al. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell. 2008;29(2):263\u201370.","journal-title":"Mol Cell"},{"issue":"6","key":"8_CR103","volume":"5","author":"JE Lee","year":"2010","unstructured":"Lee JE, Lee JY, Wilusz J, Tian B, Wilusz CJ. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One. 2010;5(6):e11201.","journal-title":"PLoS One"},{"issue":"6","key":"8_CR104","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1261\/rna.59606","volume":"12","author":"KC Moraes","year":"2006","unstructured":"Moraes KC, Wilusz CJ, Wilusz J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA. 2006;12(6):1084\u201391.","journal-title":"RNA"},{"issue":"10","key":"8_CR105","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biocel.2013.06.010","volume":"45","author":"L Timchenko","year":"2013","unstructured":"Timchenko L. Molecular mechanisms of muscle atrophy in myotonic dystrophies. Int J Biochem Cell Biol. 2013;45(10):2280\u20137.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"8_CR106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/wrna.107","volume":"3","author":"T Dasgupta","year":"2012","unstructured":"Dasgupta T, Ladd AN. The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA. 2012;3(1):104\u201321.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"16","key":"8_CR107","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/MCB.00624-10","volume":"30","author":"B Rattenbacher","year":"2010","unstructured":"Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, St Louis-Vlasova IA, Bohjanen PR. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol. 2010;30(16):3970\u201380.","journal-title":"Mol Cell Biol"},{"issue":"33","key":"8_CR108","doi-asserted-by":"crossref","first-page":"22457","DOI":"10.1074\/jbc.M802803200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang L, Lee JE, Wilusz J, Wilusz CJ. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem. 2008;283(33):22457\u201363.","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170680","volume":"12","author":"J Russo","year":"2017","unstructured":"Russo J, Lee JE, Lopez CM, Anderson J, Nguyen TP, Heck AM, Wilusz J, Wilusz CJ. The CELF1 RNA-binding protein regulates decay of signal recognition particle mRNAs and limits secretion in mouse myoblasts. PLoS One. 2017;12(1):e0170680.","journal-title":"PLoS One"},{"issue":"6\u20137","key":"8_CR110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bbagrm.2013.01.001","volume":"1829","author":"I Vlasova-St Louis","year":"2013","unstructured":"Vlasova-St Louis I, Dickson AM, Bohjanen PR, Wilusz CJ. CELFish ways to modulate mRNA decay. Biochim Biophys Acta. 2013;1829(6\u20137):695\u2013707.","journal-title":"Biochim Biophys Acta"},{"issue":"20","key":"8_CR111","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/MCB.21.20.6927-6938.2001","volume":"21","author":"NA Timchenko","year":"2001","unstructured":"Timchenko NA, Iakova P, Cai ZJ, Smith JR, Timchenko LT. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol. 2001;21(20):6927\u201338.","journal-title":"Mol Cell Biol"},{"issue":"13","key":"8_CR112","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1074\/jbc.M312923200","volume":"279","author":"NA Timchenko","year":"2004","unstructured":"Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem. 2004;279(13):13129\u201339.","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"8_CR113","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.yexcr.2008.04.018","volume":"314","author":"E Salisbury","year":"2008","unstructured":"Salisbury E, Sakai K, Schoser B, Huichalaf C, Schneider-Gold C, Nguyen H, Wang GL, Albrecht JH, Timchenko LT. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp Cell Res. 2008;314(11\u201312):2266\u201378.","journal-title":"Exp Cell Res"},{"key":"8_CR114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1479-5876-8-48","volume":"8","author":"S Gambardella","year":"2010","unstructured":"Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, Angelini C, Vergani L, Novelli G, Botta A. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med. 2010;8:48.","journal-title":"J Transl Med"},{"issue":"2","key":"8_CR115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nmd.2010.11.012","volume":"21","author":"R Perbellini","year":"2011","unstructured":"Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, Martelli F. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord. 2011;21(2):81\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"8_CR116","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/hmg\/dds478","volume":"22","author":"JM Fernandez-Costa","year":"2013","unstructured":"Fernandez-Costa JM, Garcia-Lopez A, Zuniga S, Fernandez-Pedrosa V, Felipo-Benavent A, Mata M, Jaka O, Aiastui A, Hernandez-Torres F, Aguado B, et al. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients. Hum Mol Genet. 2013;22(4):704\u201316.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8_CR117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039732","volume":"7","author":"S Greco","year":"2012","unstructured":"Greco S, Perfetti A, Fasanaro P, Cardani R, Capogrossi MC, Meola G, Martelli F. Deregulated microRNAs in myotonic dystrophy type 2. PLoS One. 2012;7(6):e39732.","journal-title":"PLoS One"},{"issue":"6","key":"8_CR118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nmd.2014.02.005","volume":"24","author":"A Perfetti","year":"2014","unstructured":"Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G, Martelli F. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord. 2014;24(6):509\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"8_CR119","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0000000000003124","volume":"87","author":"R Fernandez-Torron","year":"2016","unstructured":"Fernandez-Torron R, Garcia-Puga M, Emparanza JI, Maneiro M, Cobo AM, Poza JJ, Espinal JB, Zulaica M, Ruiz I, Martorell L, et al. Cancer risk in DM1 is sex-related and linked to miRNA-200\/141 downregulation. Neurology. 2016;87(12):1250\u20137.","journal-title":"Neurology"},{"issue":"1","key":"8_CR120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","volume":"108","author":"T Zu","year":"2011","unstructured":"Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A. 2011;108(1):260\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"R1","key":"8_CR121","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1093\/hmg\/ddt371","volume":"22","author":"JD Cleary","year":"2013","unstructured":"Cleary JD, Ranum LP. Repeat-associated non-ATG (RAN) translation in neurological disease. Hum Mol Genet. 2013;22(R1):R45\u201351.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8_CR122","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2017.08.039","volume":"95","author":"T Zu","year":"2017","unstructured":"Zu T, Cleary JD, Liu Y, Banez-Coronel M, Bubenik JL, Ayhan F, Ashizawa T, Xia G, Clark HB, Yachnis AT, et al. RAN translation regulated by Muscleblind proteins in myotonic dystrophy type 2. Neuron. 2017;95(6):1292\u20131305 e1295.","journal-title":"Neuron"},{"issue":"4","key":"8_CR123","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13311-014-0292-z","volume":"11","author":"MG Kearse","year":"2014","unstructured":"Kearse MG, Todd PK. Repeat-associated non-AUG translation and its impact in neurodegenerative disease. Neurotherapeutics. 2014;11(4):721\u201331.","journal-title":"Neurotherapeutics"},{"key":"8_CR124","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2016.04.003","volume":"1647","author":"KM Green","year":"2016","unstructured":"Green KM, Linsalata AE, Todd PK. RAN translation-what makes it run? Brain Res. 2016;1647:30\u201342.","journal-title":"Brain Res"},{"issue":"3","key":"8_CR125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","volume":"78","author":"PK Todd","year":"2013","unstructured":"Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78(3):440\u201355.","journal-title":"Neuron"},{"issue":"4","key":"8_CR126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","volume":"88","author":"M Banez-Coronel","year":"2015","unstructured":"Banez-Coronel M, Ayhan F, Tarabochia AD, Zu T, Perez BA, Tusi SK, Pletnikova O, Borchelt DR, Ross CA, Margolis RL, et al. RAN translation in Huntington disease. Neuron. 2015;88(4):667\u201377.","journal-title":"Neuron"},{"issue":"8","key":"8_CR127","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1042\/BCJ20160499","volume":"474","author":"AF Harrison","year":"2017","unstructured":"Harrison AF, Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem J. 2017;474(8):1417\u201338.","journal-title":"Biochem J"},{"issue":"6","key":"8_CR128","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neuron.2015.09.015","volume":"87","author":"H Tran","year":"2015","unstructured":"Tran H, Almeida S, Moore J, Gendron TF, Chalasani U, Lu Y, Du X, Nickerson JA, Petrucelli L, Weng Z, et al. Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a Drosophila model of C9ORF72 FTD\/ALS. Neuron. 2015;87(6):1207\u201314.","journal-title":"Neuron"},{"issue":"5","key":"8_CR129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dmm.028613","volume":"10","author":"EY Liu","year":"2017","unstructured":"Liu EY, Cali CP, Lee EB. RNA metabolism in neurodegenerative disease. Dis Models Mech. 2017;10(5):509\u201318.","journal-title":"Dis Models Mech"},{"issue":"3","key":"8_CR130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416\u201338.","journal-title":"Neuron"},{"issue":"7","key":"8_CR131","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","volume":"20","author":"E Buratti","year":"2001","unstructured":"Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001;20(7):1774\u201384.","journal-title":"EMBO J"},{"issue":"6248","key":"8_CR132","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349(6248):650\u20135.","journal-title":"Science"},{"issue":"8","key":"8_CR133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043120","volume":"7","author":"A Shiga","year":"2012","unstructured":"Shiga A, Ishihara T, Miyashita A, Kuwabara M, Kato T, Watanabe N, Yamahira A, Kondo C, Yokoseki A, Takahashi M, et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One. 2012;7(8):e43120.","journal-title":"PLoS One"},{"issue":"4","key":"8_CR134","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14(4):452\u20138.","journal-title":"Nat Neurosci"},{"issue":"10","key":"8_CR135","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/15476286.2014.996081","volume":"11","author":"L Costessi","year":"2014","unstructured":"Costessi L, Porro F, Iaconcig A, Muro AF. TDP-43 regulates beta-adducin (Add2) transcript stability. RNA Biol. 2014;11(10):1280\u201390.","journal-title":"RNA Biol"},{"issue":"23","key":"8_CR136","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/emboj.2012.292","volume":"31","author":"X Liu","year":"2012","unstructured":"Liu X, Li D, Zhang W, Guo M, Zhan Q. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J. 2012;31(23):4415\u201327.","journal-title":"EMBO J"},{"issue":"2","key":"8_CR137","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","volume":"35","author":"MJ Strong","year":"2007","unstructured":"Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci. 2007;35(2):320\u20137.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"8_CR138","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","volume":"81","author":"NH Alami","year":"2014","unstructured":"Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B, Freibaum BD, Kanagaraj A, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536\u201343.","journal-title":"Neuron"},{"issue":"43","key":"8_CR139","doi-asserted-by":"crossref","first-page":"27761","DOI":"10.1074\/jbc.273.43.27761","volume":"273","author":"L Yang","year":"1998","unstructured":"Yang L, Embree LJ, Tsai S, Hickstein DD. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem. 1998;273(43):27761\u20134.","journal-title":"J Biol Chem"},{"issue":"7200","key":"8_CR140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature06992","volume":"454","author":"X Wang","year":"2008","unstructured":"Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK, Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008;454(7200):126\u201330.","journal-title":"Nature"},{"issue":"52","key":"8_CR141","doi-asserted-by":"crossref","first-page":"20881","DOI":"10.1073\/pnas.1109434108","volume":"108","author":"J Couthouis","year":"2011","unstructured":"Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, Liu AX, Ramos D, Jethava N, Hosangadi D, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A. 2011;108(52):20881\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"8_CR142","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.b.31158","volume":"156B","author":"N Ticozzi","year":"2011","unstructured":"Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, Sapp PC, Silani V, Bosco DA, Shaw CE, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatric Genet. 2011;156B(3):285\u201390.","journal-title":"Am J Med Genet B Neuropsychiatric Genet"},{"issue":"Pt 9","key":"8_CR143","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/brain\/awr201","volume":"134","author":"M Neumann","year":"2011","unstructured":"Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, Roeber S, Kretzschmar HA, Munoz DG, Kusaka H, et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134(Pt 9):2595\u2013609.","journal-title":"Brain"},{"issue":"13","key":"8_CR144","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/hmg\/dds116","volume":"21","author":"J Couthouis","year":"2012","unstructured":"Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Mojsilovic-Petrovic J, Panossian S, et al. Evaluating the role of the FUS\/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(13):2899\u2013911.","journal-title":"Hum Mol Genet"},{"issue":"7310","key":"8_CR145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069\u201375.","journal-title":"Nature"},{"issue":"7442","key":"8_CR146","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","volume":"495","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467\u201373.","journal-title":"Nature"},{"issue":"5","key":"8_CR147","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","volume":"17","author":"JO Johnson","year":"2014","unstructured":"Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, Abramzon Y, Marangi G, Winborn BJ, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17(5):664\u20136.","journal-title":"Nat Neurosci"},{"issue":"3","key":"8_CR148","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cell.2017.08.048","volume":"171","author":"DT Murray","year":"2017","unstructured":"Murray DT, Kato M, Lin Y, Thurber KR, Hung I, McKnight SL, Tycko R. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171(3):615\u2013627 e616.","journal-title":"Cell"},{"issue":"4","key":"8_CR149","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neuron.2015.10.030","volume":"88","author":"T Murakami","year":"2015","unstructured":"Murakami T, Qamar S, Lin JQ, Schierle GS, Rees E, Miyashita A, Costa AR, Dodd RB, Chan FT, Michel CH, et al. ALS\/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88(4):678\u201390.","journal-title":"Neuron"},{"issue":"7628","key":"8_CR150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197\u2013206.","journal-title":"Nature"},{"issue":"7567","key":"8_CR151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","volume":"525","author":"BD Freibaum","year":"2015","unstructured":"Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129\u201333.","journal-title":"Nature"},{"issue":"9","key":"8_CR152","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","volume":"18","author":"A Jovicic","year":"2015","unstructured":"Jovicic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW III, Sun S, Herdy JR, Bieri G, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS. Nat Neurosci. 2015;18(9):1226\u20139.","journal-title":"Nat Neurosci"},{"issue":"7567","key":"8_CR153","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56\u201361.","journal-title":"Nature"},{"issue":"6269","key":"8_CR154","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.aad2033","volume":"351","author":"AC Woerner","year":"2016","unstructured":"Woerner AC, Frottin F, Hornburg D, Feng LR, Meissner F, Patra M, Tatzelt J, Mann M, Winklhofer KF, Hartl FU, et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351(6269):173\u20136.","journal-title":"Science"},{"issue":"3","key":"8_CR155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cell.2016.10.002","volume":"167","author":"KH Lee","year":"2016","unstructured":"Lee KH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, Cika J, Coughlin M, Messing J, Molliex A, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167(3):774\u2013788 e717.","journal-title":"Cell"},{"issue":"3","key":"8_CR156","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2016.10.003","volume":"167","author":"Y Lin","year":"2016","unstructured":"Lin Y, Mori E, Kato M, Xiang S, Wu L, Kwon I, McKnight SL. Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell. 2016;167(3):789\u2013802 e712.","journal-title":"Cell"},{"issue":"7","key":"8_CR157","doi-asserted-by":"crossref","first-page":"E1111","DOI":"10.1073\/pnas.1620293114","volume":"114","author":"KY Shi","year":"2017","unstructured":"Shi KY, Mori E, Nizami ZF, Lin Y, Kato M, Xiang S, Wu LC, Ding M, Yu Y, Gall JG, et al. Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc Natl Acad Sci U S A. 2017;114(7):E1111\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"8_CR158","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ajmg.1320510404","volume":"51","author":"RJ Hagerman","year":"1994","unstructured":"Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O\u2019Connor RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN, et al. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet. 1994;51(4):298\u2013308.","journal-title":"Am J Med Genet"},{"issue":"8","key":"8_CR159","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","volume":"146A","author":"SM Coffey","year":"2008","unstructured":"Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146A(8):1009\u201316.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"8_CR160","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","volume":"72","author":"S Jacquemont","year":"2003","unstructured":"Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, et al. Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72(4):869\u201378.","journal-title":"Am J Hum Genet"},{"issue":"Pt 8","key":"8_CR161","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/brain\/awf184","volume":"125","author":"CM Greco","year":"2002","unstructured":"Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers. Brain. 2002;125(Pt 8):1760\u201371.","journal-title":"Brain"},{"issue":"8","key":"8_CR162","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","volume":"57","author":"MA Leehey","year":"2009","unstructured":"Leehey MA. Fragile X-associated tremor\/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med. 2009;57(8):830\u20136.","journal-title":"J Investig Med"},{"key":"8_CR163","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.genom.8.080706.092249","volume":"8","author":"O Penagarikano","year":"2007","unstructured":"Penagarikano O, Mulle JG, Warren ST. The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet. 2007;8:109\u201329.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"8_CR164","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/hrt.61.3.289","volume":"61","author":"N Sreeram","year":"1989","unstructured":"Sreeram N, Wren C, Bhate M, Robertson P, Hunter S. Cardiac abnormalities in the fragile X syndrome. Br Heart J. 1989;61(3):289\u201391.","journal-title":"Br Heart J"},{"issue":"3","key":"8_CR165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5582\/irdr.2016.01048","volume":"5","author":"R Lozano","year":"2016","unstructured":"Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman RJ. Fragile X syndrome: a review of clinical management. Intractable Rare Dis Res. 2016;5(3):145\u201357.","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"8_CR166","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/70493","volume":"23","author":"SE Holmes","year":"1999","unstructured":"Holmes SE, O\u2019Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, et al. Expansion of a novel CAG trinucleotide repeat in the 5\u2032 region of PPP2R2B is associated with SCA12. Nat Genet. 1999;23(4):391\u20132.","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR167","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/WNL.56.3.299","volume":"56","author":"E O\u2019Hearn","year":"2001","unstructured":"O\u2019Hearn E, Holmes SE, Calvert PC, Ross CA, Margolis RL. SCA-12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology. 2001;56(3):299\u2013303.","journal-title":"Neurology"},{"issue":"2","key":"8_CR168","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/570","volume":"19","author":"LP Ranum","year":"1998","unstructured":"Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet. 1998;19(2):196\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR169","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10072-016-2778-4","volume":"38","author":"S Peric","year":"2017","unstructured":"Peric S, Rakocevic Stojanovic V, Mandic Stojmenovic G, Ilic V, Kovacevic M, Parojcic A, Pesovic J, Mijajlovic M, Savic-Pavicevic D, Meola G. Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2. Neurol Sci. 2017;38(3):415\u201323.","journal-title":"Neurol Sci"},{"issue":"9","key":"8_CR170","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jnnp.2009.192591","volume":"81","author":"AA Tieleman","year":"2010","unstructured":"Tieleman AA, Knoop H, van de Logt AE, Bleijenberg G, van Engelen BG, Overeem S. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. J Neurol Neurosurg Psychiatry. 2010;81(9):963\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"8_CR171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.48.1.33","volume":"48","author":"E Hund","year":"1997","unstructured":"Hund E, Jansen O, Koch MC, Ricker K, Fogel W, Niedermaier N, Otto M, Kuhn E, Meinck HM. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology. 1997;48(1):33\u20137.","journal-title":"Neurology"},{"issue":"6","key":"8_CR172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130352","volume":"10","author":"C Schneider-Gold","year":"2015","unstructured":"Schneider-Gold C, Bellenberg B, Prehn C, Krogias C, Schneider R, Klein J, Gold R, Lukas C. Cortical and subcortical grey and white matter atrophy in myotonic dystrophies Type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness. PLoS One. 2015;10(6):e0130352.","journal-title":"PLoS One"},{"issue":"10","key":"8_CR173","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","volume":"13","author":"G Meola","year":"2003","unstructured":"Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2). Neuromuscul Disord. 2003;13(10):813\u201321.","journal-title":"Neuromuscul Disord"},{"issue":"s2","key":"8_CR174","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3233\/JND-150088","volume":"2","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R. Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism. J Neuromuscul Dis. 2015;2(s2):S59\u201371.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"8_CR175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-010-0439-6","volume":"32","author":"MT Giordana","year":"2011","unstructured":"Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, Montuschi A. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci. 2011;32(1):9\u201316.","journal-title":"Neurol Sci"},{"issue":"1","key":"8_CR176","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2006-956755","volume":"27","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Woodruff BK. Frontotemporal dementia. Semin Neurol. 2007;27(1):48\u201357.","journal-title":"Semin Neurol"},{"key":"8_CR177","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2147\/NDT.S38821","volume":"10","author":"HS Kirshner","year":"2014","unstructured":"Kirshner HS. Frontotemporal dementia and primary progressive aphasia, a review. Neuropsychiatr Dis Treat. 2014;10:1045\u201355.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"14","key":"8_CR178","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddl148","volume":"15","author":"PS Thomas Jr","year":"2006","unstructured":"Thomas PS Jr, Fraley GS, Damian V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet. 2006;15(14):2225\u201338.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8_CR179","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"issue":"1","key":"8_CR180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1531-8257(199901)14:1<95::AID-MDS1016>3.0.CO;2-8","volume":"14","author":"ED Louis","year":"1999","unstructured":"Louis ED, Lee P, Quinn L, Marder K. Dystonia in Huntington\u2019s disease: prevalence and clinical characteristics. Mov Disord. 1999;14(1):95\u2013101.","journal-title":"Mov Disord"},{"issue":"4","key":"8_CR181","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/WCO.0000000000000116","volume":"27","author":"SD Kim","year":"2014","unstructured":"Kim SD, Fung VS. An update on Huntington\u2019s disease: from the gene to the clinic. Curr Opin Neurol. 2014;27(4):477\u201383.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"8_CR182","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng0194-9","volume":"6","author":"R Koide","year":"1994","unstructured":"Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6(1):9\u201313.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR183","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ng0194-14","volume":"6","author":"S Nagafuchi","year":"1994","unstructured":"Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet. 1994;6(1):14\u20138.","journal-title":"Nat Genet"},{"issue":"6","key":"8_CR184","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ana.410370610","volume":"37","author":"T Ikeuchi","year":"1995","unstructured":"Ikeuchi T, Koide R, Tanaka H, Onodera O, Igarashi S, Takahashi H, Kondo R, Ishikawa A, Tomoda A, Miike T, et al. Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol. 1995;37(6):769\u201375.","journal-title":"Ann Neurol"},{"issue":"15","key":"8_CR185","doi-asserted-by":"crossref","first-page":"13047","DOI":"10.1074\/jbc.M211224200","volume":"278","author":"FC Nucifora Jr","year":"2003","unstructured":"Nucifora FC Jr, Ellerby LM, Wellington CL, Wood JD, Herring WJ, Sawa A, Hayden MR, Dawson VL, Dawson TM, Ross CA. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem. 2003;278(15):13047\u201355.","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR186","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","volume":"95","author":"IA Klement","year":"1998","unstructured":"Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998;95(1):41\u201353.","journal-title":"Cell"},{"issue":"1","key":"8_CR187","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1385\/NMM:1:1:33","volume":"1","author":"PJ Skinner","year":"2002","unstructured":"Skinner PJ, Vierra-Green CA, Emamian E, Zoghbi HY, Orr HT. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. NeuroMolecular Med. 2002;1(1):33\u201342.","journal-title":"NeuroMolecular Med"},{"issue":"3","key":"8_CR188","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1196-277","volume":"14","author":"K Sanpei","year":"1996","unstructured":"Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet. 1996;14(3):277\u201384.","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR189","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"SM Pulst","year":"1996","unstructured":"Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14(3):269\u201376.","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"G Imbert","year":"1996","unstructured":"Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nat Genet. 1996;14(3):285\u201391.","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR191","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","volume":"8","author":"Y Kawaguchi","year":"1994","unstructured":"Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8(3):221\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR192","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ng0197-62","volume":"15","author":"O Zhuchenko","year":"1997","unstructured":"Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997;15(1):62\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR193","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng0997-65","volume":"17","author":"G David","year":"1997","unstructured":"David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17(1):65\u201370.","journal-title":"Nat Genet"},{"issue":"11","key":"8_CR194","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","volume":"8","author":"R Koide","year":"1999","unstructured":"Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet. 1999;8(11):2047\u201353.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"8_CR195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","volume":"18","author":"B Brais","year":"1998","unstructured":"Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18(2):164\u20137.","journal-title":"Nat Genet"},{"issue":"6","key":"8_CR196","doi-asserted-by":"crossref","first-page":"412","DOI":"10.18632\/aging.100567","volume":"5","author":"SY Anvar","year":"2013","unstructured":"Anvar SY, Raz Y, Verway N, van der Sluijs B, Venema A, Goeman JJ, Vissing J, van der Maarel SM, t Hoen PA, van Engelen BG, et al. A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging. Aging. 2013;5(6):412\u201326.","journal-title":"Aging"},{"issue":"4","key":"8_CR197","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng862","volume":"30","author":"P Stromme","year":"2002","unstructured":"Stromme P, Mangelsdorf ME, Shaw MA, Lower KM, Lewis SM, Bruyere H, Lutcherath V, Gedeon AK, Wallace RH, Scheffer IE, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet. 2002;30(4):441\u20135.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR198","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrg1501","volume":"6","author":"HH Ropers","year":"2005","unstructured":"Ropers HH, Hamel BC. X-linked mental retardation. Nat Rev Genet. 2005;6(1):46\u201357.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"8_CR199","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajmg.a.31151","volume":"140","author":"M Nawara","year":"2006","unstructured":"Nawara M, Szczaluba K, Poirier K, Chrzanowska K, Pilch J, Bal J, Chelly J, Mazurczak T. The ARX mutations: a frequent cause of X-linked mental retardation. Am J Med Genet A. 2006;140(7):727\u201332.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"8_CR200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2009.02.013","volume":"34","author":"C Messaed","year":"2009","unstructured":"Messaed C, Rouleau GA. Molecular mechanisms underlying polyalanine diseases. Neurobiol Dis. 2009;34(3):397\u2013405.","journal-title":"Neurobiol Dis"},{"key":"8_CR201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-9081-2-16","volume":"2","author":"S Winblad","year":"2006","unstructured":"Winblad S, Lindberg C, Hansen S. Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct. 2006;2:16.","journal-title":"Behav Brain Funct"},{"issue":"4","key":"8_CR202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/7710","volume":"21","author":"MD Koob","year":"1999","unstructured":"Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, Ranum LP. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999;21(4):379\u201384.","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/422014","volume":"75","author":"Y Ikeda","year":"2004","unstructured":"Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, Seltzer WK, Pandolfo M, Milunsky A, Potter NT, et al. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet. 2004;75(1):3\u201316.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"8_CR204","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WNO0b013e3181b416de","volume":"29","author":"HL Paulson","year":"2009","unstructured":"Paulson HL. The spinocerebellar ataxias. J Neuroophthalmol. 2009;29(3):227\u201337.","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"8_CR205","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuron.2007.07.020","volume":"55","author":"P Jin","year":"2007","unstructured":"Jin P, Duan R, Qurashi A, Qin Y, Tian D, Rosser TC, Liu H, Feng Y, Warren ST. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor\/ataxia syndrome. Neuron. 2007;55(4):556\u201364.","journal-title":"Neuron"},{"issue":"4","key":"8_CR206","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuron.2007.07.021","volume":"55","author":"OA Sofola","year":"2007","unstructured":"Sofola OA, Jin P, Qin Y, Duan R, Liu H, de Haro M, Nelson DL, Botas J. RNA-binding proteins hnRNP A2\/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron. 2007;55(4):565\u201371.","journal-title":"Neuron"},{"issue":"22","key":"8_CR207","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","volume":"24","author":"LT Timchenko","year":"1996","unstructured":"Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996;24(22):4407\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"8_CR208","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/emboj.2010.21","volume":"29","author":"C Sellier","year":"2010","unstructured":"Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ, et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 2010;29(7):1248\u201361.","journal-title":"EMBO J"},{"issue":"4","key":"8_CR209","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","volume":"66","author":"M Pieretti","year":"1991","unstructured":"Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66(4):817\u201322.","journal-title":"Cell"},{"issue":"5","key":"8_CR210","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1523\/JNEUROSCI.17-05-01539.1997","volume":"17","author":"Y Feng","year":"1997","unstructured":"Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM, Fragile X. mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci. 1997;17(5):1539\u201347.","journal-title":"J Neurosci"},{"issue":"36","key":"8_CR211","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1073\/pnas.0405398101","volume":"101","author":"EW Khandjian","year":"2004","unstructured":"Khandjian EW, Huot ME, Tremblay S, Davidovic L, Mazroui R, Bardoni B. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc Natl Acad Sci U S A. 2004;101(36):13357\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"8_CR212","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.2306-04.2004","volume":"24","author":"G Stefani","year":"2004","unstructured":"Stefani G, Fraser CE, Darnell JC, Darnell RB. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci. 2004;24(33):7272\u20136.","journal-title":"J Neurosci"},{"issue":"13","key":"8_CR213","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1073\/pnas.141145998","volume":"98","author":"WT Greenough","year":"2001","unstructured":"Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ. Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci U S A. 2001;98(13):7101\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"8_CR214","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/hmg\/ddr476","volume":"21","author":"S Hokkanen","year":"2012","unstructured":"Hokkanen S, Feldmann HM, Ding H, Jung CK, Bojarski L, Renner-Muller I, Schuller U, Kretzschmar H, Wolf E, Herms J. Lack of Pur-alpha alters postnatal brain development and causes megalencephaly. Hum Mol Genet. 2012;21(3):473\u201384.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8_CR215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002102","volume":"7","author":"A Qurashi","year":"2011","unstructured":"Qurashi A, Li W, Zhou JY, Peng J, Jin P. Nuclear accumulation of stress response mRNAs contributes to the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet. 2011;7(6):e1002102.","journal-title":"PLoS Genet"},{"key":"8_CR216","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2012.02.057","volume":"1462","author":"Y Li","year":"2012","unstructured":"Li Y, Jin P. RNA-mediated neurodegeneration in fragile X-associated tremor\/ataxia syndrome. Brain Res. 2012;1462:112\u20137.","journal-title":"Brain Res"},{"issue":"10","key":"8_CR217","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI32308","volume":"117","author":"GS Wang","year":"2007","unstructured":"Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest. 2007;117(10):2802\u201311.","journal-title":"J Clin Invest"},{"issue":"Pt 13","key":"8_CR218","first-page":"2923","volume":"118","author":"TH Ho","year":"2005","unstructured":"Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci. 2005;118(Pt 13):2923\u201333.","journal-title":"J Cell Sci"},{"issue":"3","key":"8_CR219","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/dvdy.20382","volume":"233","author":"AN Ladd","year":"2005","unstructured":"Ladd AN, Stenberg MG, Swanson MS, Cooper TA. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn. 2005;233(3):783\u201393.","journal-title":"Dev Dyn"},{"issue":"5796","key":"8_CR220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"issue":"3","key":"8_CR221","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5918","key":"8_CR222","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205\u20138.","journal-title":"Science"},{"issue":"5918","key":"8_CR223","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208\u201311.","journal-title":"Science"},{"issue":"4","key":"8_CR224","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuron.2017.07.025","volume":"95","author":"IR Mackenzie","year":"2017","unstructured":"Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808\u201316. e809","journal-title":"Neuron"},{"issue":"6","key":"8_CR225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00401-013-1201-y","volume":"126","author":"PK Todd","year":"2013","unstructured":"Todd PK. Making sense of the antisense transcripts in C9FTD\/ALS. Acta Neuropathol. 2013;126(6):785\u20137.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"8_CR226","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459\u201368.","journal-title":"Nat Neurosci"},{"issue":"17","key":"8_CR227","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182343365","volume":"77","author":"D Ito","year":"2011","unstructured":"Ito D, Suzuki N. Conjoint pathologic cascades mediated by ALS\/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology. 2011;77(17):1636\u201343.","journal-title":"Neurology"},{"issue":"1","key":"8_CR228","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.22246","volume":"69","author":"D Ito","year":"2011","unstructured":"Ito D, Seki M, Tsunoda Y, Uchiyama H, Suzuki N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS\/TLS. Ann Neurol. 2011;69(1):152\u201362.","journal-title":"Ann Neurol"},{"issue":"16","key":"8_CR229","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","volume":"29","author":"D Dormann","year":"2010","unstructured":"Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29(16):2841\u201357.","journal-title":"EMBO J"},{"key":"8_CR230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.01.016","volume":"1462","author":"OD King","year":"2012","unstructured":"King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61\u201380.","journal-title":"Brain Res"},{"issue":"4","key":"8_CR231","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cell.2012.04.017","volume":"149","author":"M Kato","year":"2012","unstructured":"Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei J, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149(4):753\u201367.","journal-title":"Cell"},{"issue":"1","key":"8_CR232","volume":"14","author":"L Lim","year":"2016","unstructured":"Lim L, Wei Y, Lu Y, Song J. ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43. PLoS Biol. 2016;14(1):e1002338.","journal-title":"PLoS Biol"},{"issue":"1","key":"8_CR233","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","volume":"163","author":"A Molliex","year":"2015","unstructured":"Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123\u201333.","journal-title":"Cell"},{"issue":"8","key":"8_CR234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000600","volume":"5","author":"RS Daughters","year":"2009","unstructured":"Daughters RS, Tuttle DL, Gao W, Ikeda Y, Moseley ML, Ebner TJ, Swanson MS, Ranum LP. RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 2009;5(8):e1000600.","journal-title":"PLoS Genet"},{"issue":"4","key":"8_CR235","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cub.2004.01.034","volume":"14","author":"M Mutsuddi","year":"2004","unstructured":"Mutsuddi M, Marshall CM, Benzow KA, Koob MD, Rebay I. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr Biol. 2004;14(4):302\u20138.","journal-title":"Curr Biol"}],"container-title":["Advances in Neurobiology","RNA Metabolism in Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-89689-2_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T22:00:35Z","timestamp":1661464835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-89689-2_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319896885","9783319896892"],"references-count":235,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-89689-2_8","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"type":"print","value":"2190-5215"},{"type":"electronic","value":"2190-5223"}],"subject":[],"published":{"date-parts":[[2018]]}}}